INTERVIEW: Bayer’s Zieler On Building An Asian Alliance Trove
This article was originally published in PharmAsia News
Bayer AG is experimenting with both traditional and new collaboration models as part of its innovation strategy and the German multinational appears keen to build on early gains in scientific hotspots in Asia. Claus Zieler, senior vice-president and head of commercial operations, Bayer pharmaceuticals division Asia-Pacific, explains how the company is faring in the region.
Register for our free email digests: